134 related articles for article (PubMed ID: 31017725)
1. Effusion cytology of epithelioid rhabdomyosarcoma.
Renshaw AA; Gould EW
Diagn Cytopathol; 2019 Oct; 47(10):1042-1044. PubMed ID: 31017725
[TBL] [Abstract][Full Text] [Related]
2. Rhabdomyosarcoma with epithelioid morphology: A challenging cytologic diagnosis in a pleural effusion.
Rodgers S; Datta L; Perry KD; Stone CH
Diagn Cytopathol; 2021 Sep; 49(9):E356-E359. PubMed ID: 34004052
[TBL] [Abstract][Full Text] [Related]
3. Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma.
Mansour MSI; Seidal T; Mager U; Dobra K; Brunnström H; Dejmek A
Cancer Cytopathol; 2021 Jun; 129(6):468-478. PubMed ID: 33493383
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary adenocarcinoma simulating malignant mesothelioma.
Tang P; Vatsia SK; Teichberg S; Kahn E
Arch Pathol Lab Med; 2001 Dec; 125(12):1598-600. PubMed ID: 11735699
[TBL] [Abstract][Full Text] [Related]
5. Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma.
Jo VY; Mariño-Enríquez A; Fletcher CD
Am J Surg Pathol; 2011 Oct; 35(10):1523-30. PubMed ID: 21921782
[TBL] [Abstract][Full Text] [Related]
6. Cytologic diagnosis of rhabdomyosarcoma in a child with a pleural effusion. A case report.
Theunissen P; Cremers M; van der Meer S; Bot F; Bras J
Acta Cytol; 2004; 48(2):249-53. PubMed ID: 15085762
[TBL] [Abstract][Full Text] [Related]
7. Cytology of sclerosing epithelioid fibrosarcoma in pleural effusion.
Tsuchido K; Yamada M; Satou T; Otsuki Y; Shimizu S; Kobayashi H
Diagn Cytopathol; 2010 Oct; 38(10):748-53. PubMed ID: 20091700
[TBL] [Abstract][Full Text] [Related]
8. EZH2, a unique marker of malignancy in effusion cytology.
Jiang H; Gupta R; Somma J
Diagn Cytopathol; 2014 Feb; 42(2):111-6. PubMed ID: 23636867
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations.
Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
Diagn Cytopathol; 2011 Jun; 39(6):395-401. PubMed ID: 21574259
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid rhabdomyosarcoma: a clinicopathological study of seven additional cases supporting a distinctive variant with aggressive biological behaviour.
Yu L; Lao IW; Wang J
Pathology; 2015 Dec; 47(7):667-72. PubMed ID: 26517641
[TBL] [Abstract][Full Text] [Related]
11. Metastatic proximal epithelioid sarcoma in pleural effusion: cytopathologic findings and differential diagnosis.
Guan H; Haque F; Ali SZ
Diagn Cytopathol; 2013 Jun; 41(6):542-5. PubMed ID: 21953993
[TBL] [Abstract][Full Text] [Related]
12. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology.
Jo VY; Cibas ES; Pinkus GS
Cancer Cytopathol; 2014 Apr; 122(4):299-306. PubMed ID: 24421209
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.
Chowdhuri SR; Fetsch P; Squires J; Kohn E; Filie AC
Diagn Cytopathol; 2014 Mar; 42(3):253-8. PubMed ID: 23161830
[TBL] [Abstract][Full Text] [Related]
14. Primary pleural epithelioid mesothelioma of clear cell type: a case report and review of current literature.
Gkogkou C; Samitas K; Foteinou M
Ultrastruct Pathol; 2011 Dec; 35(6):267-70. PubMed ID: 21978187
[TBL] [Abstract][Full Text] [Related]
15. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
Hum Pathol; 2010 May; 41(5):745-50. PubMed ID: 20060157
[TBL] [Abstract][Full Text] [Related]
16. Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology.
Gulyas M; Fillinger J; Kaposi AD; Molnar M
J Clin Pathol; 2019 Aug; 72(8):529-535. PubMed ID: 31028099
[TBL] [Abstract][Full Text] [Related]
17. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
18. Metastatic epithelioid hemangioendothelioma in a pleural effusion: diagnosis by cytology.
Abati A; Cajigas A; Hijazi YM
Diagn Cytopathol; 1994; 11(1):64-7. PubMed ID: 7956664
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanotic nerve sheath tumor in pleural effusion: Deceitful cytology with significant repercussions.
Jackson C; Linos K; Liu X
Diagn Cytopathol; 2022 Mar; 50(3):E76-E80. PubMed ID: 34698454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
